TACE联合PMCT治疗肝癌的临床分析  

Clinical Analysis of TACT Combined with PMCT in the Treatment of Liver Cancer

作　　者：姚长东 

机构地区：[1]盐城市第二人民医院,江苏盐城224000

出　　处：《中外医学研究》2017年第35期9-10,共2页CHINESE AND FOREIGN MEDICAL RESEARCH

摘　　要：目的:分析肝动脉化疗栓塞(TACE)联合冷循环经皮微波凝固(PMCT)治疗肝癌的临床效果。方法:选取2012年1月-2014年1月笔者所在医院60例肝癌患者为研究对象,分别给予TACE治疗和TACE联合PMCT治疗,比较两组治疗后的临床效果。结果:试验组的治疗总有效率和3年生存率高于对照组,差异均有统计学意义(P<0.05)。结论:肝癌患者采用TACE联合PMCT的近期疗效和远期疗效优于单独TACE治疗,值得推广。Objective：To analyze the clinical effect of transcatheter arterial chemoembolization（TACE） and cold cycle percutaneous microwave coagulation（PMCT） in the treatment of liver cancer.Method：60 patients with liver cancer from January 2012 to January 2014 in our hospital were treated with TACE and TACE combined with PMCT,and the effects were compared between the two groups after treatment.Result： The total effective rate and 3 year survival rate of the treatment group were higher than those of the control group,the differences were statistically significant（P〈0.05）.Conclusion： The short term effect and long term effect of TACE combined with PMCT in patients with liver cancer is better than that of TACE alone.It is worth promoting.

关 键 词：肝癌 TACE PMCT 治疗 

分 类 号：R735.7[医药卫生—肿瘤]